EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 50 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q4 2022. The put-call ratio across all filers is 55.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 632,138 | $6,170,000 | 2.48% |
| RP Investment Advisors LP | 1,183,905 | $11,555,000 | 1.44% |
| Arena Capital Advisors, LLC- CA | 1,362,886 | $13,302,000 | 1.22% |
| HGC Investment Management Inc. | 1,715,000 | $16,739,000 | 1.04% |
| MMCAP International Inc. SPC | 1,000,000 | $9,760,000 | 0.60% |
| DARK FOREST CAPITAL MANAGEMENT LP | 157,892 | $1,541,000 | 0.57% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,520,565 | $24,601,000 | 0.54% |
| Castle Creek Arbitrage, LLC | 728,652 | $7,108,000 | 0.35% |
| ARISTEIA CAPITAL, L.L.C. | 2,011,452 | $19,632,000 | 0.34% |
| CVI Holdings, LLC | 500,000 | $4,880,000 | 0.32% |